A different semaglutide formulation, Wegovy (semaglutide 2.4 mg), is licensed for weight management
Vision Loss (NAION) from Ozempic Use One of the most serious emerging concerns in Ozempic litigation is the potential link between GLP-1 drugs and a rare form of eye stroke called non-arteritic anterior ischemic optic neuropathy, or NAION
Combining NHS clinical experience with an MRC-funded PhD, recent NHS Clinical AI fellowship and commercial role as Chief Medical Officer at Megi health, she works at the intersection of clinical medicine, data science, technology and AI
Brand-name Mounjaro and Zepbound (manufactured by Eli Lilly) are FDA-approved for the indications above
Lifting weights prevents losing muscle, something that can happen during quick weight loss
GLP-1s are a class of medications originally developed to manage type 2 diabetes, and they are now widely utilized to support weight management